Skip to main content
Top
Gepubliceerd in: Quality of Life Research 3/2019

31-10-2018

A pilot evaluation of the expanded prostate cancer index composite for clinical practice (EPIC-CP) tool in Ontario

Auteurs: M. D. Brundage, L. Barbera, F. McCallum, D. M. Howell

Gepubliceerd in: Quality of Life Research | Uitgave 3/2019

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To introduce the EPIC-CP symptom screening tool in routine ambulatory cancer care, and to evaluate its acceptability and perceived usefulness from the perspective of patients and clinicians.

Methods

Eligible prostate cancer patients from four cancer centres were recruited (November 2014–June 2015) from radiation or surgical oncology clinics. A physician and/or health care professional reviewed the EPIC-CP results as part of the clinical encounter. Patient experience with the tool was evaluated using a nine-item Patient Exit Survey (PES). Clinician experience was evaluated through semi-structured qualitative interviews. Patient and clinician results were compared to identify common themes.

Results

A total of 333 patients were enrolled, of whom, 287 completed the PES. Most patients had one clinical encounter, although the number of EPIC-CP assessments ranged from 1 to 11 per patient, for a total of 937 EPIC-CP questionnaires completed. Item completion rates were high (91–100%), with items addressing sexual health among the lowest (91–92%). On the PES, most patients (70%) agreed with the item: “Completing this questionnaire helped me tell the clinicians about how I have been feeling”. Thematic analysis from clinician interviews revealed that the EPIC-CP captures essential prostate-specific effects that facilitated person-centred communication and customization of interventions. Targeted clinical education and patient resources were seen as necessary for uptake.

Conclusions

EPIC-CP was generally endorsed by clinicians and patients. The implementation of a disease-specific measure in place of a generic symptom screening tool has the potential to improve the quality of the clinical encounter and provide outcome measures for further health services research. Provincial implementation of this tool as a standard of care is recommended.
Literatuur
1.
go back to reference US FDA. (2009). Guidance for industry. Patient-reported outcomes measures: Use in medical product development to support labeling claims. Federal Registrer, 74(35), 65132–65133. US FDA. (2009). Guidance for industry. Patient-reported outcomes measures: Use in medical product development to support labeling claims. Federal Registrer, 74(35), 65132–65133.
2.
go back to reference Acquadro, C., Berzon, R., Dubois, D., et al. (2001). Incorporating the patient’s perspective into drug development and communication: An ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration. Value in Health, 16, 522–531. Acquadro, C., Berzon, R., Dubois, D., et al. (2001). Incorporating the patient’s perspective into drug development and communication: An ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration. Value in Health, 16, 522–531.
3.
go back to reference Au, H.-J., Ringash, J., Brundage, M., et al. Added value of health-related quality of life measurement in cancer clinical trials: The experience of the NCIC CTG. Expert Review of Pharmacoeconomics & Outcomes Research 10(2), 119–128, 2010.CrossRef Au, H.-J., Ringash, J., Brundage, M., et al. Added value of health-related quality of life measurement in cancer clinical trials: The experience of the NCIC CTG. Expert Review of Pharmacoeconomics & Outcomes Research 10(2), 119–128, 2010.CrossRef
4.
go back to reference Till, J. E., Osoba, D., Pater, J. L., & Young, J. R. (1994). Research on health-related quality of life: Dissemination into practical applications. Quality of Life Research, 3, 279–283.CrossRefPubMed Till, J. E., Osoba, D., Pater, J. L., & Young, J. R. (1994). Research on health-related quality of life: Dissemination into practical applications. Quality of Life Research, 3, 279–283.CrossRefPubMed
5.
go back to reference Lipscomb, J., Gotay, C., & Snyder, C. (2005). Outcomes assessment in cancer: Measures, methods, and applications. Cambridge: Cambridge University Press. Lipscomb, J., Gotay, C., & Snyder, C. (2005). Outcomes assessment in cancer: Measures, methods, and applications. Cambridge: Cambridge University Press.
6.
go back to reference Snyder, C. F., & Aaronson, N. K. (2009). Use of patient-reported outcomes in clinical practice. Lancet, 374(9687), 369–370.CrossRefPubMed Snyder, C. F., & Aaronson, N. K. (2009). Use of patient-reported outcomes in clinical practice. Lancet, 374(9687), 369–370.CrossRefPubMed
7.
go back to reference Brundage, M., & Snyder, C. (2012). Patient-reported outcomes in clinical practice: Using standards to break down barriers. Clinical Investigation, 2, 343–346.CrossRef Brundage, M., & Snyder, C. (2012). Patient-reported outcomes in clinical practice: Using standards to break down barriers. Clinical Investigation, 2, 343–346.CrossRef
8.
go back to reference Greenhalgh, J., & Meadows, K. (1999). The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: A literature review. Journal of Evaluation in Clinical Practice, 5, 401–416.CrossRefPubMed Greenhalgh, J., & Meadows, K. (1999). The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: A literature review. Journal of Evaluation in Clinical Practice, 5, 401–416.CrossRefPubMed
9.
go back to reference Marshall, S., Haywood, K., Fitzpatrick, R.. Haywood, S., & Fitzpatrick, K. (2006). Impact of patient-reported outcome measures on routine practice [abstract] Marshall. Journal of Evaluation in Clinical Practice, 12, 559–568.CrossRefPubMed Marshall, S., Haywood, K., Fitzpatrick, R.. Haywood, S., & Fitzpatrick, K. (2006). Impact of patient-reported outcome measures on routine practice [abstract] Marshall. Journal of Evaluation in Clinical Practice, 12, 559–568.CrossRefPubMed
10.
go back to reference Howell, D., Molloy, S., Wilkinson, K., et al. (2015). Patient-reported outcomes in routine cancer clinical practice: A scoping review of use, impact on health outcomes, and implementation factors. [review]. Annals of Oncology, 26, 1846–1858.CrossRefPubMed Howell, D., Molloy, S., Wilkinson, K., et al. (2015). Patient-reported outcomes in routine cancer clinical practice: A scoping review of use, impact on health outcomes, and implementation factors. [review]. Annals of Oncology, 26, 1846–1858.CrossRefPubMed
11.
go back to reference Velikova, G., Booth, L., Smith, A. B., et al. (2004). Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. Journal of Clinical Oncology, 22, 714–724.CrossRefPubMed Velikova, G., Booth, L., Smith, A. B., et al. (2004). Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. Journal of Clinical Oncology, 22, 714–724.CrossRefPubMed
12.
go back to reference Berry, D. L., Blumenstein, B. A., Halpenny, B., et al. (2011). Enhancing patient-provider communication with the electronic self-report assessment for cancer: A randomized trial. Journal of Clinical Oncology, 29, 1029–1035.CrossRefPubMedPubMedCentral Berry, D. L., Blumenstein, B. A., Halpenny, B., et al. (2011). Enhancing patient-provider communication with the electronic self-report assessment for cancer: A randomized trial. Journal of Clinical Oncology, 29, 1029–1035.CrossRefPubMedPubMedCentral
13.
go back to reference Santana, M. J., Feeny, D., Johnson, J. A., et al. (2010). Assessing the use of health-related quality of life measures in the routine clinical care of lung-transplant patients. Quality of Life Research, 19, 371–379.CrossRefPubMed Santana, M. J., Feeny, D., Johnson, J. A., et al. (2010). Assessing the use of health-related quality of life measures in the routine clinical care of lung-transplant patients. Quality of Life Research, 19, 371–379.CrossRefPubMed
14.
go back to reference Detmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002). Health related quality of life assessments and patient physician communication. Journal of the American Medical Association, 288, 3027–3034.CrossRefPubMed Detmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002). Health related quality of life assessments and patient physician communication. Journal of the American Medical Association, 288, 3027–3034.CrossRefPubMed
15.
go back to reference Seow, H., Sussman, J., Martelli-Reid, L., Pond, G., & Bainbridge, D. (2012). Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. Journal of Oncology Practice/American Society of Clinical Oncology, 8, e142–e148.CrossRef Seow, H., Sussman, J., Martelli-Reid, L., Pond, G., & Bainbridge, D. (2012). Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. Journal of Oncology Practice/American Society of Clinical Oncology, 8, e142–e148.CrossRef
16.
go back to reference Basch, E., Deal, A. M., Kris, M. G., et al. (2016). Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. Journal of Clinical Oncology, 20(18), 2198. Basch, E., Deal, A. M., Kris, M. G., et al. (2016). Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. Journal of Clinical Oncology, 20(18), 2198.
17.
go back to reference Basch, E., Deal, A. M., Dueck, A. C., et al. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 318, 197–198.CrossRefPubMedPubMedCentral Basch, E., Deal, A. M., Dueck, A. C., et al. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 318, 197–198.CrossRefPubMedPubMedCentral
18.
go back to reference Denis, F., Lethrosne, C., Pourel, N., et al. (2017). Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. Journal of the National Cancer Institute, 109, 2017.CrossRef Denis, F., Lethrosne, C., Pourel, N., et al. (2017). Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. Journal of the National Cancer Institute, 109, 2017.CrossRef
19.
go back to reference Wu, A. W., Kharrazi, H., Boulware, L. E., & Snyder, C. F. (2013). Measure once, cut twice–adding patient-reported outcome measures to the electronic health record for comparative effectiveness research. Journal of Clinical Epidemiology, 66, Suppl–S20.CrossRef Wu, A. W., Kharrazi, H., Boulware, L. E., & Snyder, C. F. (2013). Measure once, cut twice–adding patient-reported outcome measures to the electronic health record for comparative effectiveness research. Journal of Clinical Epidemiology, 66, Suppl–S20.CrossRef
20.
go back to reference Barbera, L., Sutradhar, R., Howell, D., et al. (2015). Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy? Supportive Care in Cancer, 23, 3025–3032.CrossRefPubMed Barbera, L., Sutradhar, R., Howell, D., et al. (2015). Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy? Supportive Care in Cancer, 23, 3025–3032.CrossRefPubMed
21.
go back to reference Barbera, L., Atzema, C., Sutradhar, R., et al. (2013). Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. Annals of Emergency Medicine, 61, 427–437.CrossRefPubMed Barbera, L., Atzema, C., Sutradhar, R., et al. (2013). Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. Annals of Emergency Medicine, 61, 427–437.CrossRefPubMed
22.
go back to reference Sanda, M. G., Dunn, R. L., Michalski, J., et al. (2008). Quality of life and satisfaction with outcome among prostate-cancer survivors. The New England Journal of Medicine, 358, 1250–1261.CrossRefPubMed Sanda, M. G., Dunn, R. L., Michalski, J., et al. (2008). Quality of life and satisfaction with outcome among prostate-cancer survivors. The New England Journal of Medicine, 358, 1250–1261.CrossRefPubMed
23.
go back to reference Litwin, M. S. (1995). Health-related quality of life after treatment for localized prostate cancer. Cancer, 75, 2000–2003.CrossRef Litwin, M. S. (1995). Health-related quality of life after treatment for localized prostate cancer. Cancer, 75, 2000–2003.CrossRef
24.
go back to reference Madalinska, J. B., Essink-Bot, M. L., de Koning, H. J., Kirkels, W. J., van der Maas, P. J., & Schroder, F. H. (2001). Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. Journal of Clinical Oncology, 19, 1619–1628.CrossRefPubMed Madalinska, J. B., Essink-Bot, M. L., de Koning, H. J., Kirkels, W. J., van der Maas, P. J., & Schroder, F. H. (2001). Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. Journal of Clinical Oncology, 19, 1619–1628.CrossRefPubMed
25.
go back to reference Rodrigues, G., Yao, X., Loblaw, D. A., Brundage, M., & Chin, J. L., Genitourinary Cancer Disease Site Group (2013). Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer. Canadian Urological Association Journal, 7, E411–E416.CrossRefPubMedPubMedCentral Rodrigues, G., Yao, X., Loblaw, D. A., Brundage, M., & Chin, J. L., Genitourinary Cancer Disease Site Group (2013). Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer. Canadian Urological Association Journal, 7, E411–E416.CrossRefPubMedPubMedCentral
26.
go back to reference Berry, D. L., Wang, Q., Halpenny, B., & Hong, F. (2012). Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer. Patient Education and Counseling, 88, 262–267.CrossRefPubMedPubMedCentral Berry, D. L., Wang, Q., Halpenny, B., & Hong, F. (2012). Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer. Patient Education and Counseling, 88, 262–267.CrossRefPubMedPubMedCentral
27.
go back to reference Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care, 7, 6–9.PubMedCrossRef Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care, 7, 6–9.PubMedCrossRef
28.
go back to reference Pereira, J., Green, E., Molloy, S., et al. (2014). Population-based standardized symptom screening: Cancer Care Ontario’s Edmonton Symptom Assessment System and performance status initiatives. Journal of Oncology Practice/American Society of Clinical Oncology, 10, 212–214.CrossRef Pereira, J., Green, E., Molloy, S., et al. (2014). Population-based standardized symptom screening: Cancer Care Ontario’s Edmonton Symptom Assessment System and performance status initiatives. Journal of Oncology Practice/American Society of Clinical Oncology, 10, 212–214.CrossRef
29.
go back to reference Pereira, J. L., Chasen, M. R., Molloy, S., et al. (2016). Cancer care professionals’ attitudes toward systematic standardized symptom assessment and the Edmonton Symptom Assessment System after large-scale population-based implementation in Ontario, Canada. Journal of Pain & Symptom Management, 51, 662–672.CrossRef Pereira, J. L., Chasen, M. R., Molloy, S., et al. (2016). Cancer care professionals’ attitudes toward systematic standardized symptom assessment and the Edmonton Symptom Assessment System after large-scale population-based implementation in Ontario, Canada. Journal of Pain & Symptom Management, 51, 662–672.CrossRef
30.
go back to reference Greenhalgh, J., Long, A. F., & Flynn, R. (2005). The use of patient reported outcome measures in routine clinical practice: Lack of impact or lack of theory?. [Review] [59 refs]. Social Science & Medicine, 60, 833–843.CrossRef Greenhalgh, J., Long, A. F., & Flynn, R. (2005). The use of patient reported outcome measures in routine clinical practice: Lack of impact or lack of theory?. [Review] [59 refs]. Social Science & Medicine, 60, 833–843.CrossRef
31.
go back to reference Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000). Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology, 56(6), 899–905.CrossRefPubMed Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000). Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology, 56(6), 899–905.CrossRefPubMed
32.
go back to reference Korzeniowski, M., Kalyvas, M., Mahmud, A., et al. (2016). Piloting prostate cancer patient-reported outcomesin clinical practice. Supportive Care in Cancer, 24, 1983–1990.CrossRefPubMed Korzeniowski, M., Kalyvas, M., Mahmud, A., et al. (2016). Piloting prostate cancer patient-reported outcomesin clinical practice. Supportive Care in Cancer, 24, 1983–1990.CrossRefPubMed
33.
go back to reference Sandelowski, M., & Barraso, J. (2003). Classifying the findings in qualitative studies. Qualitative Health Research, 13, 905–923.CrossRefPubMed Sandelowski, M., & Barraso, J. (2003). Classifying the findings in qualitative studies. Qualitative Health Research, 13, 905–923.CrossRefPubMed
34.
go back to reference Neergaard, M. A., Olesen, F., Andersen, R. S., & Sondergaard, J. (2009). Qualitative description: The poor cousin of health research? BMC Medical Research Methodology, 9, 52.CrossRefPubMedPubMedCentral Neergaard, M. A., Olesen, F., Andersen, R. S., & Sondergaard, J. (2009). Qualitative description: The poor cousin of health research? BMC Medical Research Methodology, 9, 52.CrossRefPubMedPubMedCentral
35.
go back to reference Watanabe, S. M., Nekolaichuk, C. L., & Beaumont, C. (2012). Palliative care providers’ opinions of the edmonton symptom assessment system revised (ESAS-r) in clinical practice. Journal of Pain & Symptom Management, 44, e2–e3.CrossRef Watanabe, S. M., Nekolaichuk, C. L., & Beaumont, C. (2012). Palliative care providers’ opinions of the edmonton symptom assessment system revised (ESAS-r) in clinical practice. Journal of Pain & Symptom Management, 44, e2–e3.CrossRef
36.
go back to reference Chang, P., Szymanski, K. M., Dunn, R. L., et al. (2011). Expanded prostate cancer index composite for clinical practice: Development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer. Journal of Urology, 186, 865–872.CrossRefPubMed Chang, P., Szymanski, K. M., Dunn, R. L., et al. (2011). Expanded prostate cancer index composite for clinical practice: Development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer. Journal of Urology, 186, 865–872.CrossRefPubMed
37.
go back to reference Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33, 159–174.CrossRefPubMed Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33, 159–174.CrossRefPubMed
38.
go back to reference Graneheim, U. H., & Lundman, B. (2004). Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Education Today, 24, 105–112.CrossRefPubMed Graneheim, U. H., & Lundman, B. (2004). Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Education Today, 24, 105–112.CrossRefPubMed
Metagegevens
Titel
A pilot evaluation of the expanded prostate cancer index composite for clinical practice (EPIC-CP) tool in Ontario
Auteurs
M. D. Brundage
L. Barbera
F. McCallum
D. M. Howell
Publicatiedatum
31-10-2018
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2019
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-2034-x

Andere artikelen Uitgave 3/2019

Quality of Life Research 3/2019 Naar de uitgave